today financial review stated that intersuisse bioscience managers bought the 7 million plus shares sold by qic yesterday at 45 cents .will prove to be a very good buy as the following brokers have target for acr/ abn amro morgans $2.05,pattersons$1.90,shaws$1.40 and wilson htm $2.62.acr will be profitable in 2010 with a great pipeline of new products.the main reason the stock is so low is that qic has been sitting on the stock for over 15 months.
Add to My Watchlist
What is My Watchlist?
